This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated SEMA4D Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-SEMA4D WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~96.2 kDa | |
| Gel | 8–10% (standard starting point) | |
| Positive control | Adipose tissue (IHC candidate; verify WB) +4 more | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Glycosylated + Phosphorylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 2 isoform(s) |
The M02512-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | SH-SY5Y cell lysate (catalog M02512-1) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M02512-1; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
SEMA4D has a predicted full-length mass of 96.2 kDa; glycosylation, signal peptide cleavage, isoforms, and homodimerization could affect migration, but none establishes an observed band size.
| Band near 96.2 kDa | consistent with the predicted full-length precursor, pending band-identity controls |
| Band above 96.2 kDa | N-linked glycosylation may increase apparent size |
| Band slightly below the precursor | signal peptide cleavage may yield a smaller mature protein |
| Band near twice the monomer size | a homodimer may persist under non-reducing conditions |
| Several bands at different positions | isoforms 1 and 2 may contribute if their migration differs |
| Predicted full-length mass | 96.2 kDa provides the sequence-based reference |
| N-linked glycosylation at Asn49, Asn77, Asn139, Asn191, Asn329, Asn379, Asn419, and Asn613 | may increase apparent size or broaden migration if glycan occupancy varies |
| Homodimer formation | may produce a band near twice the monomer size if the dimer persists during electrophoresis |
| Splice isoforms 1 and 2 | may differ in size, but distinct bands are not established |
| Signal peptide at residues 1–21 | cleavage may make the mature protein smaller than the full-length precursor |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Membrane protein may be poorly recovered during extraction | Check membrane enrichment and use a positive-control lysate |
| Band higher than expected | N-linked glycosylation or persistent homodimer | Compare deglycosylated and reducing preparations with an identity control |
| Band lower than expected | Signal peptide cleavage or an isoform may alter size | Check antibody epitope coverage and confirm identity with knockdown |
| Broad smear instead of sharp band | Variable N-linked glycosylation may broaden migration | Compare untreated and deglycosylated samples |
| Multiple bands | Isoforms 1 and 2 or incompletely reduced homodimer may contribute | Compare reducing conditions and verify bands by knockdown |
| Weak or no signal | Incomplete extraction of membrane-associated SEMA4D | Check membrane protein recovery and include a positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | High | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | High | Protein (IHC) | HPA → |
| Cerebellum | Purkinje cells | High | Protein (IHC) | HPA → |
| Cervix | squamous epithelial cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Caudate | neuronal cells | Low | Protein (IHC) | HPA → |
| Smooth muscle | smooth muscle cells | Low | Protein (IHC) | HPA → |
| Appendix | glandular cells | Medium | Protein (IHC) | HPA → |
| Breast | glandular cells | Medium | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Medium | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for SEMA4D, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
M02512-1 is a rabbit monoclonal anti-SEMA4D antibody listed with human reactivity. Its Western blot image shows Semaphorin 4D/CD100 expression in SH-SY5Y cell lysate. No other tested contexts are supplied.
Which to pick: M02512-1 is the only listed option. It has a Western blot image from SH-SY5Y cell lysate and is listed as reactive with human samples; performance in other sample contexts is not documented here.